Correction: Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies

QR Code

Correction: Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies

Enregistré dans:

Détails bibliographiques
Format:	article
Langue:	EN
Publié:	BMJ Publishing Group 2021
Sujets:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/2c3cf6c0e6c8463c9d2bb0fba7795f9c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types
par: Marco Donia, et autres
Publié: (2021)

Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication
par: Fangfang Liu, et autres
Publié: (2021)

PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine
par: Mariaelena Pierobon, et autres
Publié: (2021)

DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer
par: Rish K Pai, et autres
Publié: (2021)

Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
par: Federica Cappuccini, et autres
Publié: (2021)

Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy
par: James Harber, et autres
Publié: (2021)

The Oncogenic Role and Immune Infiltration for CARM1 Identified by Pancancer Analysis
par: Kui Liu, et autres
Publié: (2021)

Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling
par: Feng Liu, et autres
Publié: (2017)

Circulating tumor cells: quintessential precision oncology presenting challenges for biology
par: Rebecca J. Morris
Publié: (2017)

Correction: Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
Publié: (2021)

Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes
par: Kazuhiro Kakimi, et autres
Publié: (2021)

Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients
par: Yves Boucher, et autres
Publié: (2021)

Correction: Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity
Publié: (2021)

Correction: IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy
Publié: (2021)

Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology
par: Frank P. Lin, et autres
Publié: (2021)

A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial
par: Istvan Petak, et autres
Publié: (2021)

Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
par: Alberto Mantovani, et autres
Publié: (2021)

Clinical implications of systemic and local immune responses in human angiosarcoma
par: Jason Yongsheng Chan, et autres
Publié: (2021)

Correction: Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
Publié: (2021)

Correction: MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer
Publié: (2021)

Multiplex imaging reveals the architecture of the tumor immune microenvironment
par: Junlei Zhang, et autres
Publié: (2021)

Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study
par: Apostolia Maria Tsimberidou, et autres
Publié: (2021)

Identification of an Immune-Related Biomarker Model Based on the CircRNA-Associated Regulatory Network for Esophageal Carcinoma
par: Zhaonian Hu, et autres
Publié: (2021)

Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy
par: Sjoerd H van der Burg, et autres
Publié: (2021)

Correction notice to “Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model”
par: Chiao-Fang Teng, et autres
Publié: (2021)

Correction: In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
Publié: (2021)

Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival
par: Vladimir Lazar, et autres
Publié: (2021)

Surgical Insights Are Essential to Integration of Immune Therapy in Resectable NSCLC
par: Jessica S. Donington, MD
Publié: (2021)

Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors
par: Ben‐Yuan Jiang, et autres
Publié: (2021)

Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity
par: Shunichi Taki, et autres
Publié: (2021)

Precision oncology- the future of personalized cancer medicine?
par: Ann M. Bode, et autres
Publié: (2017)

Precision medicine: the foundation of future cancer therapeutics
par: Seung Ho Shin, et autres
Publié: (2017)

Artificial intelligence for the next generation of precision oncology
par: Pedro J. Ballester, et autres
Publié: (2021)

Correction: Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids
Publié: (2021)

Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma
par: Frank Riemer, et autres
Publié: (2021)

Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward
par: David Munn, et autres
Publié: (2021)

Distinct mutational profile and immune microenvironment in microsatellite-unstable and POLE-mutated tumors
par: Hee Sang Hwang, et autres
Publié: (2021)

Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
par: Ruining Gong, et autres
Publié: (2021)

Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
Publié: (2021)

Immune landscape in vulvar cancer-draining lymph nodes indicates distinct immune escape mechanisms in support of metastatic spread and growth
par: Gemma G Kenter, et autres
Publié: (2021)